Biomea Fusion is trading 16.79% down at $1.41 in after-hours trading, after closing at $1.71 on September 22, 2026; no clear company-specific catalyst was identified.

  • Available coverage identified no September 22 company-specific announcement, earnings release, regulatory action or analyst change.
  • COVALENT-211 enrollment completion and the OPAL study predate the move; broader markets were mixed rather than sharply risk-off.